Neuromuscular Disorders

Featured Article

Differentiating Multiple Sclerosis Mimics on MRI

Differentiating Multiple Sclerosis Mimics on MRI

A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.

Latest

In Multiple Sclerosis, Hand Strength May Indicate Disease Status

In Multiple Sclerosis, Hand Strength May Indicate Disease Status

In patients with MS, hand function often correlates with measures of quality of life.

Multiple Sclerosis May Have Causal Link to Osteoporosis

Multiple Sclerosis May Have Causal Link to Osteoporosis

The prevalence of osteoporosis was greater in patients with MS than in matched controls.

In MS, Anxiety, Cognitive Fatigue May Affect Visual Memory

In MS, Anxiety, Cognitive Fatigue May Affect Visual Memory

Cognitive fatigue and anxiety are common symptoms reported by patients with multiple sclerosis.

Multiple Sclerosis Relapse Rate Linked to Puberty in Boys

Multiple Sclerosis Relapse Rate Linked to Puberty in Boys

Boys with onset of MS during puberty experienced an increased rate of relapse compared with boys with MS onset before or after puberty.

New Amyotrophic Lateral Sclerosis Tx Approved by FDA

New Amyotrophic Lateral Sclerosis Tx Approved by FDA

Radicava is the first approved treatment for ALS in over 20 years.

Vitamin D Deficiency Affects Cognition in Multiple Sclerosis

Vitamin D Deficiency Affects Cognition in Multiple Sclerosis

Longer studies are needed to further evaluate the effect of vitamin D supplementation on cognition in multiple sclerosis.

Pediatric Multiple Sclerosis Linked to Epstein-Barr, Herpes Simplex Virus Exposure

Pediatric Multiple Sclerosis Linked to Epstein-Barr, Herpes Simplex Virus Exposure

Increased risk of pediatric multiple sclerosis was observed in patients with prior exposure to EBV, HSV-1, and vitamin D deficiency.

In Relapsing MS, Fatigue, Limb Problems May Signal Risk for Disease Conversion

In Relapsing MS, Fatigue, Limb Problems May Signal Risk for Disease Conversion

In older patients with relapsing multiple sclerosis, patient-reported fatigue and problems with lower extremities may signal conversion to secondary progressive disease.

No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate

No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate

More participants achieved clinical NEDA with DMF than placebo over 2 years in the integrated analysis.

Ocrelizumab Approved for Progressive, Relapsing Multiple Sclerosis

Ocrelizumab Approved for Progressive, Relapsing Multiple Sclerosis

The biannual infusion is approved for the treatment of adults with relapsing and progressive forms of multiple sclerosis.

Sign Up for Free e-newsletters